Journal of Diabetology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Opinion Article - Journal of Diabetology (2022) Volume 6, Issue 1

Effect of environmental factors on type 2 diabetes mellitus.

Jennifer A *

Department of Preventive Medicine, Center for Genetic Epidemiology, University of Southern California, Los Angeles, CA, USA

*Corresponding Author:
Jennifer A
Department of Preventive Medicine
Center for Genetic Epidemiology
University of Southern California
Los Angeles, CA, USA
E-mail: acheyj@usc.edu

Received: 29-Dec-2021, Manuscript No. AADY-22-101; Editor assigned: 30-Dec-2021, PreQC No. AADY-22-101(PQ); Reviewed: 16-Jan-2022, QC No AADY-22-101; Revised: 19-Jan-2022, Manuscript No. AADY-22-101(R); Published: 27-Jan-2022, DOI:10.35841/aady-6.1.101

Citation: Jennifer A. Effect of environmental factors on type 2 diabetes mellitus. J Diabetol. 2022;6(1):101

Visit for more related articles at Journal of Diabetology

Introduction

The pathophysiology of type 2 diabetes mellitus is defined by peripheral insulin resistance, poor hepatic glucose production management, and declining -cell activity, which eventually leads to -cell failure. The major occurrences are assumed to be initial insulin secretion deficiencies and, in many cases, relative insulin insufficiency in combination with peripheral insulin resistance. Dietary factors, endocrine disruptors and other environmental toxins, and the composition of the gut microbiota have all been related to type 1 and type 2 diabetes. Obesity and insulin resistance may operate as type 1 diabetes accelerators in addition to their well-known role in type 2 diabetes. Islet autoimmunity associated to putative environmental variables (e.g., diet, infection) may play a role in a subgroup of people diagnosed with type 2 diabetes..

Pathogenesis of type 2 diabetes mellitus

For the insulin response to begin, glucose must be transported across the blood-brain barrier and coupled to a glucose sensor. The glucose/glucose sensor complex generates an increase in glucokinase by preserving the protein and limiting its degradation. Inducing glucokinase is the first step in connecting intermediate metabolism to the insulin secretory pathway. In type 2 diabetes individuals' -cells, glucose transfer appears to be significantly reduced, shifting the control point for insulin generation from glucokinase to the glucose transport system. Sulfonylureas aid in the correction of this issue [1].

Later in the disease's course, the second phase release of freshly generated insulin is hampered, an effect that can be partially restored, at least in some patients, by reinstalling strict glycemia control. Desensitization, also known as -cell glucotoxicity, is caused by glucose's paradoxical inhibitory effect on insulin release, and is thought to be caused by the accumulation of glycogen within the -cell as a result of persistent hyperglycemia. Nonenzymatic glycation of -cell proteins or sorbital accumulation in the -cell have both been proposed as possibilities.

In type 2 diabetes, alterations in -cell activity include glucose potentiation in response to nonglucose insulin secretagogues, asynchronous insulin release, and a decreased conversion of proinsulin to insulin. An impairment in first phase insulin secretion in patients with past gestational diabetes may serve as a measure of risk for type 2 diabetes mellitus in family members of people with type 2 diabetes mellitus. Impaired first-phase insulin production, on the other hand, will not cause glucose tolerance problems. Because chronic hyperinsulinemia inhibits both insulin secretion and action, and hyperglycemia can impair both the insulin secretory response to glucose and cellular insulin sensitivity, the precise relationship between glucose and insulin level as a surrogate measure of insulin resistance has been questioned. Insulin sensitivity in lean type 2 diabetes patients over 65 was shown to be comparable to age-matched nondiabetic controls. Obesity is almost usually present in people with type 2 diabetes who are insulin resistant [2]. .

Because chronic hyperinsulinemia inhibits each hypoglycemic agent secretion and action, and symptom will impair each the hypoglycemic agent body fluid response to aldohexose and cellular hypoglycemic agent sensitivity, the precise relationship between aldohexose and hypoglycemic agent level as a surrogate live of hypoglycemic agent resistance has been questioned. hypoglycemic agent sensitivity in lean sort a pair of polygenic disease patients over sixty five was shown to be like age-matched nondiabetic controls. blubber is nearly sometimes gift in folks with sort a pair of polygenic disease World Health Organization area unit hypoglycemic agent resistant [3]..

Insulin's ability to limit viscus aldohexose synthesis each abstinence and postprandially is traditional in first-degree relatives of sort a pair of polygenic disorder patients. Each abstinence and postprandial aldohexose production increase as sort a pair of polygenic disorder progresses. Viscus internal secretion resistance is outlined by a substantial reduction in glucokinase activity and a chemical action hyperbolic conversion of substrates to aldohexose despite the presence of internal secretion. As a result, patients with sort a pair of diabetes' livers square measure pre-programmed to each overproduce and underuse aldohexose. Higher amounts of free fatty acids are associated to hyperbolic viscus aldohexose production in sort a pair of polygenic disorder.

Environmental factors in type 2 diabetes mellitus

Type 2 diabetes develops when B-cells fail to produce enough insulin to meet demand, usually in the context of developing insulin resistance. Islet autoimmunity affects a tiny percentage of type 2 diabetes patients. Obesity is a major risk factor for type 2 diabetes, which has a complex genetic and environmental aetiology [4].

Insulin resistance develops as a result of ectopic fat buildup in the liver and muscle. B-cell function may be reduced, islet inflammation may occur, and B-cell mortality may occur as a result of fat accumulation in the pancreas. Varying persons develop type 2 diabetes at different levels of BMI/body fat composition, with Asians and Asian Americans having a lower BMI

There may be a personal "fat threshold" beyond which ectopic fat accumulates, causing insulin resistance and B-cell decompensation in individuals who are susceptible. Weight loss improves insulin sensitivity in the liver and skeletal muscle while also reducing pancreatic fat accumulation. Insulin secretion abnormalities in prediabetes and type 2 diabetes with a recent onset are at least partially reversible with calorie restriction and weight loss. Long-term diabetes is difficult to cure, even with the significant weight loss associated with bariatric surgery.

Obesity and diabetes are associated to a reduction in sleep duration as well as an increase in sleep time. Obstructive sleep apnea has been associated to type 2 diabetes and the metabolic syndrome, as well as a reduction in the length and quality of sleep. The current "24-hour culture" may lead to less sleep and an increased risk of type 2 diabetes as a result. While there are associations with other environmental variables, there have been no direct causal relationships established thus far [5].

References

  1. Lapidus L, Bengtsson C, Larsson B, et al, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J. 1984;289:1257-61.

    2. Indexed at, Cross Ref

  2. Hartz AJ, Rupley DC, Kalkhoff RK, et al. Relationship of obesity to diabetes: influences of obesity level and body-fat distribution.. Prey Med. 1983;12:351-57.

    3. Google scholar, Cross Ref

  3. Evans DJ, Hoffmann RG, Kalkhoff RK, et al. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism. 1984;33(1):68-75.

    4. Google scholar, Cross Ref

  4. Peiris AN, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med. 1989;110(11):867-72.

    5. Indexed at, Google scholar, Cross Ref

  5. Chute CG, Baron JA, Plymate SR, et al. Sex hormones and coronary artery disease. Am J Med. 1987;83(5):853-59.

    6. Indexed at, Google scholar, Cross Ref

Get the App